
The Rise of Daycare Oncology in Karnataka's Hospitals
Expanding Access Through Daycare Chemotherapy
Daycare chemotherapy is rapidly becoming the standard for cancer treatment across Karnataka's government and private hospitals. Specifically, nearly 80% of patients now receive their infusion therapies without needing overnight hospitalization. This shift significantly reduces the burden on tertiary care centers like the Kidwai Memorial Institute of Oncology. Consequently, patients can access high-quality treatment closer to their homes. Furthermore, the daycare model supports better bed management and lowers overall healthcare costs for both providers and patients.
Clinical Advantages of Outpatient Oncology
Doctors highlight several clinical benefits associated with the outpatient delivery of cancer drugs. Primarily, shorter infusion times and improved drug tolerability allow patients to return home the same day. This approach minimizes disruptions to daily life and fosters a more comfortable recovery environment. Additionally, the risk of hospital-acquired infections decreases when patients spend less time in a traditional inpatient setting. However, medical teams still reserve inpatient care for roughly 10% of complex cases, such as leukemia or severe sarcoma. Thus, the model provides a balanced approach to modern oncology by prioritizing efficiency for the majority.
Implementing the Hub-and-Spoke Model
The Karnataka government established 16 District Daycare Chemotherapy Centres (DDCCs) in June 2025 to decentralize cancer care effectively. These centers follow a hub-and-spoke model where primary centers refer complex queries to specialist institutes for guidance. For instance, the Mysuru District Hospital has successfully treated dozens of patients through multiple cycles without requiring transfers to the capital. This decentralization ensures that patients from rural areas do not have to travel long distances for routine sessions. Moreover, the state plans to expand this network to further improve clinical adherence and long-term patient outcomes across the region.
Frequently Asked Questions
Q1: What are the main benefits of daycare chemotherapy for patients?
Daycare chemotherapy offers lower treatment costs, a reduced risk of hospital-acquired infections, and the comfort of recovering at home with family support.
Q2: Who is eligible for daycare treatment versus inpatient admission?
Most oncology patients are eligible for daycare services; however, complex cases like leukemia or patients requiring intensive side-effect monitoring still need inpatient admission.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
- Daycare chemotherapy gaining traction in Karnataka's govt hospitals amid rise incancer cases - ETHealthworld
- Karnataka Health Department - District Daycare Chemotherapy Centres (DDCC) Initiative 2025.
- Indian Journal of Medical and Paediatric Oncology - Outpatient Chemotherapy Trends in India.

More from MedShots Daily

Karnataka's shift to daycare chemotherapy reduces inpatient stays, cuts costs, and improves patient comfort through an expanded hub-and-spoke model....
last month

A study explores how blueberry leaf extract suppresses IL-1β and induces autophagy, highlighting its potential for managing inflammatory disorders....
Today

This article discusses Japanese radiation laws, focusing on the 5 mSv/3 months dose limit for women and the timing of pregnancy awareness....
Today

High-quality plant-based diets improve cardiometabolic markers like HDL-C and insulin sensitivity in pregnant women, prioritizing food quality over meat exc...
Today

Scalable holographic recording creates high-performance mechanochromic elastomers for advanced stress sensing and artificial skin applications....
Today

New research shows cationic nanoplastics sequester Lipid A to form coronas that impair TLR4 signaling and prevent the development of endotoxin tolerance....
Today